NCT05493826View on ClinicalTrials.gov

Real World Study on the Use of Cemiplimab in Adult Patients in UK

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

November 1, 2022

Study Completion Date

November 1, 2022

Conditions
Cutaneous Squamous Cell Carcinoma
Interventions
OTHER

No intervention

Non-interventional study based on secondary use of hospital medical record

Trial Locations (1)

RG6 1PT

Sanofi-Aventis UK, Reading

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT05493826 - Real World Study on the Use of Cemiplimab in Adult Patients in UK | Biotech Hunter | Biotech Hunter